From: A DNA methylation-based test for esophageal cancer detection
Clinicopathological Features | Esophageal Tumor Samples | Normal Esophagus | |
---|---|---|---|
Naïve Tumors | Post ChT/RTa Treatment Tumors | ||
Patients (no.) | 88 | 36 | 56 |
Age median (range) | 63 (37–83) | 60 (44–73) | 66 (36–84) |
Sex (no.) | |||
Man | 74 | 31 | 37 |
Woman | 14 | 5 | 19 |
Histological subtype (no.) | n.a. | ||
Adenocarcinoma | 40 | 16 | |
Squamous Cell Carcinoma | 48 | 20 | |
Localization (no.) | n.a. | ||
Upper | 3 | – | |
Middle | 27 | 5 | |
Lower | 30 | 18 | |
GEJb | 28 | 13 | |
pT Stage/ypT Stage | n.a. | ||
pT1/ypT1 | 16 | 5 | |
pT2/ypT2 | 14 | 7 | |
pT3/ypT3 | 56 | 23 | |
pT4/ypT4 | 2 | 1 | |
pN Stage/ ypN Stage | n.a. | ||
pN0/ypN0 | 39 | 17 | |
pN1/ypN1 | 17 | 7 | |
pN2/ypN2 | 21 | 6 | |
pN3/ypN3 | 11 | 6 | |
Stage | n.a. | ||
I | 13 | 4 | |
II | 32 | 6 | |
III | 28 | 19 | |
IV | 15 | 7 |